ArticleBMC cancer2019
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
David A Palma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
139 papers cite itlatest 60 shown
this paperpooled ittrialcites it